68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer
68Ga-RM2 PET/CT for Detection of Regional Nodal and Distant Metastases in Patients With Intermediate and High-Risk Prostate Cancer
Sponsor: Andrei Iagaru
A PHASE2 clinical study on Stage II Prostate Adenocarcinoma and Stage III Prostate Adenocarcinoma, this trial is completed. The trial is conducted by Andrei Iagaru and has accumulated 12 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2024 — Jul 2024 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Jun 2023 — Jan 2024 [monthly]
Active Not Recruiting PHASE2
-
Jul 2022 — Jun 2023 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
▶ Show 7 earlier versions
-
Jan 2021 — Jul 2022 [monthly]
Recruiting PHASE2
Status: Suspended → Recruiting
-
Aug 2020 — Jan 2021 [monthly]
Suspended PHASE2
Status: Recruiting → Suspended
-
Feb 2020 — Aug 2020 [monthly]
Recruiting PHASE2
-
Jan 2019 — Feb 2020 [monthly]
Recruiting PHASE2
-
Jun 2018 — Jan 2019 [monthly]
Recruiting PHASE2
-
Jun 2017 — Jun 2018 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
May 2017 — Jun 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Apr 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Andrei Iagaru
For direct contact, visit the study record on ClinicalTrials.gov .